Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA appropriations

This article was originally published in The Gray Sheet

Executive Summary

Device center program funding levels increase $13.9 mil. from FY 2001 under Senate Appropriations Committee bill (S 1191). The amount is consistent with FDA estimates for bringing review times within statutory requirements in the short term. The measure, adopted by the Senate Oct. 25, earmarks $178.8 mil. for CDRH and for related field activities in the Office of Regulatory Affairs. The House version, passed in June, includes roughly $179.5 mil. for CDRH (1"The Gray Sheet" June 18, 2001, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015643

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel